Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Cited by (1,001)

Items 101–200 of 1,001

1. The Chemical Biology of Ferroptosis in the Central Nervous System
   Rajiv R. Ratan · 2020 · Cell chemical biology
2. Stroke intervention pathways: NMDA receptors and beyond
   Ted Weita Lai, Woei‐Cherng Shyu, Yu Tian Wang · 2011 · Trends in Molecular Medicine
3. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
   David H. Hackos, Patrick J. Lupardus, Teddy Grand, Yelin Chen, Tzu-Ming Wang, Paul Reynen, Amy E. Gustafson, Heidi J.A. Wallweber, Matthew Volgraf, Benjamin D. Sellers et al. · 2016 · Neuron
4. The role of the immune system in posttraumatic stress disorder
   Şeyma Katrinli, Nayara Cristina dos Santos Oliveira, Jennifer C. Felger, Vasiliki Michopoulos, Alicia K. Smith · 2022 · Translational Psychiatry
5. The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults
   Marc‐André Martel, Tomás J. Ryan, Karen F. S. Bell, Jill H. Fowler, Aoife McMahon, Bashayer R Al-Mubarak, Noboru H. Komiyama, Karen J. Horsburgh, Peter C. Kind, Seth G. N. Grant et al. · 2012 · Neuron
6. Synaptic pathology: A shared mechanism in neurological disease
   Christopher M. Henstridge, Eleanor K. Pickett, Tara L. Spires‐Jones · 2016 · Ageing Research Reviews
7. Organization, control and function of extrasynaptic NMDA receptors
   Thomas Papouin, Stéphane H. R. Oliet · 2014 · Philosophical Transactions of the Royal Society B Biological Sciences
8. Current approaches to enhance glutamate transporter function and expression
   Andréia C. K. Fontana · 2015 · Journal of Neurochemistry
9. The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease
   Carolyn C. Rudy, Holly C. Hunsberger, Daniel S. Weitzner, Miranda N. Reed · 2015 · Aging and Disease
10. The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases
    Alison Todd, Giles E. Hardingham · 2020 · International Journal of Molecular Sciences
11. Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
    Ajay Sarawagi, Narayan Datt Soni, Anant Bahadur Patel · 2021 · Frontiers in Psychiatry
12. Neuron–Microglia Interactions in Mental Health Disorders: “For Better, and For Worse”
    Eric S. Wohleb · 2016 · Frontiers in Immunology
13. Differential role of NR2A and NR2B subunits in N-Methyl-D-Aspartate receptor antagonist-induced aberrant cortical gamma oscillations
    Kocsis, Bernat · 2012 · Biological Psychiatry
14. Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
    Sanacora, Gerard, Schatzberg, Alan F · 2015 · Neuropsychopharmacology
15. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer’s disease
    Shan Ping Yu, Michael Qize Jiang, Seong S. Shim, Soheila Pourkhodadad, Ling Wei · 2023 · Molecular Neurodegeneration
16. Neuroimmune Basis of Alcoholic Brain Damage
    Fulton T. Crews, Ryan P. Vetreno · 2014 · International review of neurobiology
17. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants
    Jing Yan, C. Peter Bengtson, Bettina Buchthal, Anna M. Hagenston, Hilmar Bading · 2020 · Science
18. Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders
    Susan M.G. Goody, Matthew L. Baum, Constantinos D. Paspalas, Stephanie M. Fernandez, Nikisha Carty, Pradeep K. Kurup, Paul J. Lombroso · 2011 · Pharmacological Reviews
19. Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations
    Hilmar Bading · 2017 · The Journal of Experimental Medicine
20. Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease
    Simoni, Elena, Daniele, Simona, Bottegoni, Giovanni, Pizzirani, Daniela, Trincavelli, Maria L., Goldoni, Luca, Tarozzo, Glauco, Reggiani, Angelo, Martini, Claudia, Piomelli, Daniele et al. · 2012 · Journal of Medicinal Chemistry
21. The neurobiology of methamphetamine induced psychosis
    Jennifer H. Hsieh, Dan Joseph Stein, Fleur Margaret Howells · 2014 · Frontiers in Human Neuroscience
22. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
    Marquard, Jan, Otter, Silke, Welters, Alena, Stirban, Alin, Fischer, Annelie, Eglinger, Jan, Herebian, Diran, Kletke, Olaf, Klemen, Maša Skelin, Stožer, Andraž et al. · 2015 · Nature Medicine
23. Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia
    Uddin, Md. Sahab, Rahman, Md. Motiar, Jakaria, Md., Rahman, Md. Sohanur, Hossain, Md. Sarwar, Islam, Ariful, Ahmed, Muniruddin, Mathew, Bijo, Omar, Ulfat Mohammed, Barreto, George E. et al. · 2020 · Molecular Neurobiology
24. Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia
    Adam J. Funk, Robert Erne McCullumsmith, Vahram H. Haroutunian, James H. Meador‐Woodruff · 2011 · Neuropsychopharmacology
25. Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
    Mark J. Niciu, Dawn Flosnik Ionescu, Erica M. Richards, Carlos A. Zarate · 2013 · Journal of Neural Transmission
26. Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
    Miller, Andrew H, Haroon, Ebrahim, Felger, Jennifer C · 2017 · Neuropsychopharmacology
27. Alterations in synaptic function and plasticity in Huntington disease
    Amy Smith-Dijak, Marja D. Sepers, Lynn A. Raymond · 2019 · Journal of Neurochemistry
28. Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
    Haroon, Ebrahim, Miller, Andrew H. · 2016 · Current Topics in Behavioral Neurosciences
29. Activity-dependent calcium signaling and ERK-MAP kinases in neurons: A link to structural plasticity of the nucleus and gene transcription regulation
    J. Simon Wiegert, Hilmar Bading · 2010 · Cell Calcium
30. Regulation of NMDA glutamate receptor functions by the GluN2 subunits
    Vieira, Marta, Yong, Xuan Ling Hilary, Roche, Katherine W., Anggono, Victor · 2020 · Journal of Neurochemistry
31. Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
    Francisco J. Carvajal, Hayley A. Mattison, Waldo F. Cerpa · 2016 · Neural Plasticity
32. Serine Metabolism in Health and Disease and as a Conditionally Essential Amino Acid
    Milan Holeček · 2022 · Nutrients
33. GABAergic Control of Depression-Related Brain States
    Luscher, Bernhard, Fuchs, Thomas · 2015 · Advances in Pharmacology
34. Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N-methyl-d-aspartate Receptor Function and Neuronal Excitotoxicity
    Xianju Zhou, Qi Ding, Zhuoyou Chen, Huifang Yun, Hongbing Wang · 2013 · Journal of Biological Chemistry
35. NMDA receptors: linking physiological output to biophysical operation
    Gary J. Iacobucci, Gabriela Popescu · 2017 · Nature reviews. Neuroscience
36. Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration
    Patricia Rodriguez‐Rodriguez, E Fernandez, Ángeles Almeida, Juan Pedro Bolaños · 2012 · Cell Death and Differentiation
37. NMDA and AMPA receptors dysregulation in Alzheimer's disease
    Parvin Babaei · 2021 · European Journal of Pharmacology
38. An Increase in Synaptic NMDA Receptors in the Insular Cortex Contributes to Neuropathic Pain
    Shuang Qiu, Tao Chen, Kohei Koga, Yanyan Guo, Hui Xu, Qian Song, Jiejie Wang, Giannina Descalzi, Bong‐Kiun Kaang, Jianhong Luo et al. · 2013 · Science Signaling
39. Analysis of free d-serine in mammals and its biological relevance
    Toru Nishikawa · 2011 · Journal of Chromatography B
40. Glutamate-mediated excitotoxicity in schizophrenia: a review.
    E. Plitman, S. Nakajima, C. de la Fuente-Sandoval, P. Gerretsen, M. Chakravarty, Jane Kobylianskii, J. Chung, F. Caravaggio, Y. Iwata, G. Remington et al. · 2014 · European Neuropsychopharmacology
41. Pathophysiological Bases of Comorbidity: Traumatic Brain Injury and Post-Traumatic Stress Disorder
    Gary B. Kaplan, Kimberly A. Leite‐Morris, Lei Wang, Kendra K. Rumbika, Stephen C. Heinrichs, Xiang Zeng, Liquan Wu, Danielle T. Arena, Yang Dong Teng · 2017 · Journal of Neurotrauma
42. Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
    Amaia Ezkurdia, María Javier Ramírez, Maite Solas · 2023 · International Journal of Molecular Sciences
43. Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
    Paul C. Trippier, Kristin Jansen Labby, Dustin D. Hawker, Jan Mataka, Richard B. Silverman · 2013 · Journal of Medicinal Chemistry
44. Distinct Roles for μ-Calpain and m-Calpain in Synaptic NMDAR-Mediated Neuroprotection and Extrasynaptic NMDAR-Mediated Neurodegeneration
    Yubin Wang, Víctor Briz, Athar H. Chishti, Xiaoning Bi, Michel Baudry · 2013 · Journal of Neuroscience
45. NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders
    Charles F. Zorumski, Yukitoshi Izumi · 2012 · Neuroscience & Biobehavioral Reviews
46. Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
    Chih‐Chia Huang, I‐Hua Wei, Chieh-Liang Huang, Kuang-Ti Chen, Mang‐Hung Tsai, Priscilla Tsai, Rene Tun, Kuo-Hao Huang, Yue‐Cune Chang, Hsien‐Yuan Lane et al. · 2013 · Biological Psychiatry
47. Synaptic NMDA Receptors Mediate Hypoxic Excitotoxic Death
    Christine M. Wroge, Joshua Hogins, Larry Eisenman, Steven J. Mennerick · 2012 · Journal of Neuroscience
48. Calcium Signaling in Synapse-to-Nucleus Communication
    Anna M. Hagenston, Hilmar Bading · 2011 · Cold Spring Harbor Perspectives in Biology
49. Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
    Baxter, Paul S., Bell, Karen F.S., Hasel, Philip, Kaindl, Angela M., Fricker, Michael, Thomson, Derek, Cregan, Sean P., Gillingwater, Thomas H., Hardingham, Giles E. · 2015 · Nature Communications
50. A Signaling Cascade of Nuclear Calcium-CREB-ATF3 Activated by Synaptic NMDA Receptors Defines a Gene Repression Module That Protects against Extrasynaptic NMDA Receptor-Induced Neuronal Cell Death and Ischemic Brain Damage
    Sheng‐Jia Zhang, Bettina Buchthal, David Lau, Stefanie N. Hayer, Oliver Dick, Markus Schwaninger, Roland C. Veltkamp, Ming Zou, Ursula Keller Weiss, Hilmar Bading · 2011 · Journal of Neuroscience
51. Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory
    Hausrat, Torben J., Muhia, Mary, Gerrow, Kimberly, Thomas, Philip, Hirdes, Wiebke, Tsukita, Sachiko, Heisler, Frank F., Herich, Lena, Dubroqua, Sylvain, Breiden, Petra et al. · 2015 · Nature Communications
52. Molecular bases of NMDA receptor subtype‐dependent properties
    Nathan G. Glasgow, Beth Siegler Retchless, Jon W. Johnson · 2014 · The Journal of Physiology
53. Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease
    Eduardo Elias Benarroch · 2018 · Neurology
54. Hippocampal Sclerosis: Causes and Prevention
    Matthew C. Walker · 2015 · Seminars in Neurology
55. Ubiquitin pathways in neurodegenerative disease
    Graham Atkin, Henry Lauris Paulson · 2014 · Frontiers in Molecular Neuroscience
56. Astrocyte, a Promising Target for Mood Disorder Interventions
    Zhou, Xinyi, Xiao, Qian, Xie, Li, Yang, Fan, Wang, Liping, Tu, Jie · 2019 · Frontiers in Molecular Neuroscience
57. Corticostriatal synaptic adaptations in Huntington's disease
    Joshua L. Plotkin, Dalton James Surmeier · 2015 · Current Opinion in Neurobiology
58. Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability
    Balázs Zoltán Pál · 2018 · Cellular and Molecular Life Sciences
59. NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss
    Tackenberg, C, Grinschgl, S, Trutzel, A, Santuccione, A C, Frey, M C, Konietzko, U, Grimm, J, Brandt, R, Nitsch, R M · 2013 · Cell Death & Disease
60. Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
    Jason M. Dwyer, Ronald S. Duman · 2013 · Biological Psychiatry
61. Lipid rafts, synaptic transmission and plasticity: Impact in age-related neurodegenerative diseases
    Ana Maria Sebastião, Mariana Colino-Oliveira, Natália Assaife‐Lopes, Raquel B. Dias, Joaquim Alexandre Ribeiro · 2012 · Neuropharmacology
62. Control of mitochondrial physiology and cell death by the Bcl-2 family proteins Bax and Bok
    Beatrice D’Orsi, Julia Mateyka, Jochen H.M. Prehn · 2017 · Neurochemistry International
63. Ion Channel Functions in Early Brain Development
    Richard S. Smith, Christopher A. Walsh · 2020 · Trends in Neurosciences
64. Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc
    Charles T. Anderson, Robert J. Radford, Melissa L. Zastrow, Daniel Yang Zhang, Ulf‐Peter Apfel, Stephen J. Lippard, Thanos Tzounopoulos · 2015 · Proceedings of the National Academy of Sciences
65. Prion Protein and Copper Cooperatively Protect Neurons by Modulating NMDA Receptor Through S-nitrosylation
    Lisa Gasperini, Elisa Meneghetti, Beatrice Pastore, Federico Benetti, Giuseppe Legname · 2014 · Antioxidants and Redox Signaling
66. Emerging mechanisms of disrupted cellular signaling in brain ischemia
    Michael Tymianski · 2011 · Nature Neuroscience
67. Synaptic dysfunction and septin protein family members in neurodegenerative diseases
    Mikael Marttinen, Kaisa M. A. Kurkinen, Hilkka S. Soininen, Annakaisa Haapasalo, Mikko O. Hiltunen · 2015 · Molecular Neurodegeneration
68. Opposing Roles of Synaptic and Extrasynaptic NMDA Receptor Signaling in Cocultured Striatal and Cortical Neurons
    Alexandra M. Kaufman, Austen J. Milnerwood, Marja D. Sepers, Ainsley Coquinco, Kevin She, Liang Wang, Hwan Lee, Ann Marie Craig, Max S. Cynader, Lynn A. Raymond · 2012 · Journal of Neuroscience
69. Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
    Richard Macrez, Peter K. Stys, Denis Vivien, Stuart A. Lipton, Fabián Docagne · 2016 · The Lancet Neurology
70. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage
    Federico Nicolás Soria, Alberto Pérez‐Samartín, Abraham Martín, Kiran Babu Gona, Jordi Llop, Bogusław Szczupak, Juan Carlos Chara, Carlos Matute, Marı́a Domercq · 2014 · Journal of Clinical Investigation
71. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
    Mary-Anne B. MacKay, Maryana Kravtsenyuk, Rejish K. Thomas, Nicholas Mitchell, Serdar Murat Dursun, Glen B. Baker · 2019 · Frontiers in Psychiatry
72. TRPM2 channel-mediated cell death: An important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions
    Philippa Malko, Lin‐Hua Jiang · 2020 · Redox Biology
73. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
    Marja D. Sepers, Lynn A. Raymond · 2014 · Drug Discovery Today
74. The Tau/A152T mutation, a risk factor for frontotemporal‐spectrum disorders, leads to NR2B receptor‐mediated excitotoxicity
    Jochen Martin Decker, Lars Krüger, Astrid Sydow, Frank J.A. Dennissen, Zuzana Šišková, Eckhard Mandelkow�, Eva‐Maria Mandelkow · 2016 · EMBO Reports
75. Cdk5: Multitasking between physiological and pathological conditions
    João Pedro Lopes, Paula M. Agostinho · 2011 · Progress in Neurobiology
76. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3
    Marta Mota Vieira, Joana Fernandes, Laura C. Carreto, Berta Anuncibay Soto, Manuel A. S. Santos, Jiahuai Han, Arsenio Fernández‐López, Carlos Bandeira Duarte, Ana Luı́sa Carvalho, Armanda E. Santos · 2014 · Neurobiology of Disease
77. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, Michael Tilghman Treadway, Ebrahim Haroon, Jennifer C. Felger, Andrew H. Miller · 2021 · Pharmacological Reviews
78. Multiple sclerosis: molecular pathogenesis and therapeutic intervention
    Imane Boutitah-Benyaich, Herena Eixarch, Javier Villacieros‐Álvarez, Arnau Hervera, Álvaro Cobo‐Calvo, Xavier Montalbán, Carmen Espejo · 2025 · Signal Transduction and Targeted Therapy
79. Biological development of reading circuits
    Brian Arie Wandell, Jason D. Yeatman · 2013 · Current Opinion in Neurobiology
80. Enhanced astrocytic d-serine underlies synaptic damage after traumatic brain injury
    Enmanuel J. Perez, Stephen A. Tapanes, Zachary B. Loris, Darrick T. Balu, Thomas J. Sick, Joseph T. Coyle, Daniel J. Liebl · 2017 · Journal of Clinical Investigation
81. DAPK1–p53 Interaction Converges Necrotic and Apoptotic Pathways of Ischemic Neuronal Death
    Lei Pei, You Shang, Huijuan Jin, Shan Wang, Na Wei, Honglin Yan, Yan Wu, Chengye Yao, Xiaoxi Wang, Ling‐Qiang Zhu et al. · 2014 · Journal of Neuroscience
82. 3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
    Ana Laura Colín-González, Perla D. Maldonado, Abel Santamarı́a · 2012 · NeuroToxicology
83. Distribution of Extrasynaptic NMDA Receptors on Neurons
    Ronald S. Petralia · 2012 · The Scientific World JOURNAL
84. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease
    Javier Becerril-Ortega, Karim Bordji, Thomas Fréret, Travis Rush, Alain Buisson · 2014 · Neurobiology of Aging
85. From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy
    Hailin Zheng, Mati Fridkin, Moussa B. H. Youdim · 2014 · Pharmaceuticals
86. Ketamine as a promising prototype for a new generation of rapid‐acting antidepressants
    Abdallah, Chadi G., Averill, Lynnette A., Krystal, John H. · 2015 · Annals of the New York Academy of Sciences
87. Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models
    Sònia Marco, Albert Giralt, Milos M Petrovic, Mahmoud A. Pouladi, Rebeca Martínez-Turrillas, José Martínez Hernández, Linda S. Kaltenbach, Jesús F. Torres-Peraza, Rona K. Graham, Masahiko Watanabe et al. · 2013 · Nature Medicine
88. Does kynurenic acid act on nicotinic receptors? An assessment of the evidence
    Trevor W. Stone · 2019 · Journal of Neurochemistry
89. Rhythmic light flicker rescues hippocampal low gamma and protects ischemic neurons by enhancing presynaptic plasticity
    Lifeng Zheng, Mei Yu, Rui Lin, Yunxuan Wang, Zhan Zhuo, Ning Cheng, Mengzhen Wang, Yongqiang Tang, Liping Wang, Sheng‐Tao Hou · 2020 · Nature Communications
90. Recent insights into the mode of action of memantine and ketamine
    Jon W. Johnson, Nathan G. Glasgow, Nadezhda V. Povysheva · 2014 · Current Opinion in Pharmacology
91. From Intrinsic Firing Properties to Selective Neuronal Vulnerability in Neurodegenerative Diseases
    Francesco Roselli, Pico Caroni · 2015 · Neuron
92. Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms
    Nadia Cattane, Juliet Richetto, Annamaria Cattaneo · 2018 · Neuroscience & Biobehavioral Reviews
93. Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering
    Pereira, Ana C., Lambert, Hilary K., Grossman, Yael S., Dumitriu, Dani, Waldman, Rachel, Jannetty, Sophia K., Calakos, Katina, Janssen, William G., McEwen, Bruce S., Morrison, John H. · 2014 · Proceedings of the National Academy of Sciences
94. Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
    Pereira, A C, Gray, J D, Kogan, J F, Davidson, R L, Rubin, T G, Okamoto, M, Morrison, J H, McEwen, B S · 2017 · Molecular Psychiatry
95. Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα
    Bruce G. Mockett, Max Richter, Wickliffe C. Abraham, Ulrike Müller · 2017 · Frontiers in Molecular Neuroscience
96. NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
    Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, Mst. Marium Begum, Shammi Akhter, Ariful Islam, Bijo Mathew, Md. Siddiqul Islam, Md. Shah Amran, Ghulam Md Ashraf · 2019 · Current Pharmaceutical Design
97. BDNF Reduces Toxic Extrasynaptic NMDA Receptor Signaling via Synaptic NMDA Receptors and Nuclear-Calcium-Induced Transcription of inhba/Activin, A
    Lau, David, Bengtson, C. Peter, Buchthal, Bettina, Bading, Hilmar · 2015 · Cell Reports
98. Developmental Expression of N-Methyl-d-Aspartate (NMDA) Receptor Subunits in Human White and Gray Matter: Potential Mechanism of Increased Vulnerability in the Immature Brain
    Lauren L. Jantzie, Delia M. Talos, Michele C. Jackson, Hyun‐Kyung Park, Dionne A. Graham, Mirna Lechpammer, Rebecca Dunn Folkerth, Joseph J. Volpe, Frances E. Jensen · 2013 · Cerebral Cortex
99. The overlooked aspect of excitotoxicity: Glutamate‐independent excitotoxicity in traumatic brain injuries
    Joel Tehse, Changiz Taghibiglou · 2018 · European Journal of Neuroscience
100. Beyond the critical point: An overview of excitotoxicity, calcium overload and the downstream consequences
     Daniele Bano, Maria Ankarcrona · 2017 · Neuroscience Letters